RTI-336
RTI-336, also known as RTI-4229-336 or LS-193,309 is a potent and selective dopamine reuptake inhibitor that was initially developed by the Research Triangle Institute, now known as RTI International. == Pharmacology == It is a phenyltropane derivative that binds to the dopamine transporter with approximately 20 times the affinity of cocaine.